VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Thursday, January 1, 2026
Stock Comparison
Cintas Corporation vs GSK plc
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Cintas Corporation
CTAS · NASDAQ
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Cintas Corporation's moat claims, evidence, and risks.
View CTAS analysisGSK plc
GSK · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Cintas Corporation leads (63 / 100 vs 62 / 100 for GSK plc).
- Segment focus: Cintas Corporation has 3 segments (77.1% in Uniform Rental and Facility Services); GSK plc has 3 segments (37.6% in Specialty Medicines).
- Primary market structure: Competitive vs Oligopoly. Pricing power: Moderate vs Strong.
- Moat breadth: Cintas Corporation has 5 moat types across 2 domains; GSK plc has 4 across 3.
Primary market context
Cintas Corporation
Uniform Rental and Facility Services
B2B uniform rental and route-based facility services (entrance mats, restroom supplies, towels/mops, etc.)
North America (primarily United States; also Canada and Latin America)
Businesses (SMB to large enterprise) via local delivery routes and branches
Service operator / rental provider (route-based distribution and processing network)
77.1%
GSK plc
Specialty Medicines
Branded specialty pharmaceuticals (HIV, oncology, immunology/respiratory)
Global
Hospitals, specialist physicians, payers
Innovator & branded manufacturer
37.6%
Side-by-side metrics
Moat coverage
Shared moat types
Cintas Corporation strengths
GSK plc strengths
Segment mix
Cintas Corporation segments
Full profile >Uniform Rental and Facility Services
Competitive
First Aid and Safety Services
Competitive
All Other (Fire Protection Services and Uniform Direct Sale)
Competitive
GSK plc segments
Full profile >Vaccines
Oligopoly
Specialty Medicines
Oligopoly
General Medicines
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.